NYS Attorney General files suit against GlaxoSmithKline for Concealing Drug Information Wed, 2 Jun 2004 The most positive development in the antidepressant drug saga is the filing of a much needed lawsuit by Eliot Spitzer, New York State Attorney General. The suit charges GlaxoSmithKline with having “engaged in repeated and…
Psychiatrist Scolds the APA After Winning Distinguished Fellow Award/ NYC Sues 44 Pharma Companies Fri, 6 Aug 2004 After receiving a 50-year “distinguished fellow award” from the American Psychiatric Association in May, 2004, Alex Braiman, M.D. a practicing psychiatrist, wrote a letter acknowledging that the APA’s “advocacy of unsupported “biologic”…
Family Wonders if Prozac Prompted School Shootings Sat, 26 Mar 2005 The New York Times reports that family members of Jeffe Weise, the Mennesota student who went on a shooting rampage, believe that Prozac "could have been the final straw" that triggered Weise to kill. “They kept upping the dose…
LA Times: NIH Dissident Scientists Hire Drug Industry Lawyers–Evidence of Journalistic Shilling Fri, 22 Apr 2005 Pulitzer Prize winner David Willman of the Los Angeles Times, whose investigative reporting first revealed the major covert conflicts of interest among top scientists and administrators at the National Institutes of Health (NIH), reports…
Pfizer issues prosecutors a manual to defend drug – Star Ledger Thu, 5 Aug 2004 In the May 14, 2004, settlement of a lawsuit initiated by a whistleblower, Pfizer pleaded guilty to criminal fraud in the promotion of Neurontin, and agreed to pay $430 million. https://ahrp.org/infomail/04/05/16.php A report in The…
Cong. Hinchey calls for ouster of FDA Counsel Sen. Bingaman & Reed tell FDA: disclose all trial info Thu, 15 Jul 2004 Wish I’d said that: “Having Daniel Troy as chief legal counsel of the FDA, is like placing John Gotti in charge of the Justice Department.” (Tom Woodward, whose…
VIOXX – Merck–MEDCO – a case study Wed, 13 Oct 2004 Vioxx: A case study in how a lethal drug is marketed and dispensed – without MINIMAL safeguards to protect people’s lives. Merck marketed and sold billions of dollars worth of Vioxx through MEDCO–the largest Medicare Pharmacy Benefit Manager (PBM)…
Associated Press: More Details about FDA Warning Strattera Associated with Suicide Thu, 29 Sep 2005 On April 26, 2004, we wrote: “The Alliance for Human Research Protection is concerned that children who are prescribed the failed antidepressant, Strattera, may be exposed to undisclosed serious risks of harm. FDA’s-approved label states:…
Tell the Truth About Antidepressants On Drug Labels & in Medical Journals Thu, 16 Sep 2004 An April, 2004 editorial in the New York Times noted: “What seems most astonishing is the skimpy evidence that these drugs work at all in most young patients.” What is astonishing is how the…
A request for comment about NIH proposed new research misconduct rule
See Fed Register:
http://ori.dhhs.gov/multimedia/acrobat/42CFRParts50and93.pdf
The new rule, I believe is meant to protect research institutions from the effective sting of a knowledgeable whistle blower.
The new rule would redefine whistle-blower as “complainant” and would limit the role of the complainant. Under the old rule, the whistle-blower participated in the process helping investigators by leading them to the evidence, etc.
Unlawful drug marketing: GlaxoSmithKline & 4,000 doctors Face Criminal Charges in Italy Mon, 7 Jun 2004 On March 25, 2004, the US Attorney in Pennsylvania commenced an investigation of Eli Lilly’s marketing promotion of Zyprexa (olanzapine), Prozac (fluoxetine) and Evista (raloxifene). On April 19, a class action lawsuit was filed…
Two Court Rulings Reject Pfizer-FDA Preemption Claim in Zoloft “failure to warn” cases Thu, 21 Jul 2005 In a stunning federal court order JAMES M. ROSENBAUM, US Chief District Judge in Minnesota, overturned FDA-supported pre-emption arguments in their entirety! “The FDA has no authority to declare, ipse dixit, that a…
